- Papers in database
- 5
- Years active
- 2019 – 2023
- Health outcomes studied
- 3
Health Outcomes Studied
Papers (5)
- 2023Maternal supplementation with Limosilactobacillus reuteri FN041 for preventing infants with atopic dermatitis: study protocol for a randomized controlled trial10.3389/fmicb.2023.1267448
- 2022Prevention of High-Fat Diet-Induced Hypercholesterolemia by Lactobacillus reuteri Fn041 Through Promoting Cholesterol and Bile Salt Excretion and Intestinal Mucosal Barrier Functions10.3389/fnut.2022.851541
- 2022Breast Milk-Derived Limosilactobacillus reuteri Prevents Atopic Dermatitis in Mice via Activating Retinol Absorption and Metabolism in Peyer's Patches.10.1002/mnfr.202200444
- 2022Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission10.3389/fnut.2022.987400
- 2019Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet.10.1039/c9fo00417c